Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1996
10/02/1996EP0734247A1 Cosmetic and/or pharmaceutical preparations
10/02/1996EP0653943A4 Targeting somatic gene therapy to joints.
10/02/1996EP0597850B1 Crystalline interleukin-4
10/02/1996EP0575497B1 Dna sequences which code for virulence characteristics of -$(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by -$(s. suis) in mammals, including man
10/02/1996EP0487617B1 Synthetic peptides that enhance cell binding
10/02/1996EP0485578B1 Neurotropic growth factors comprising a homeobox peptide
10/02/1996EP0480071B1 S-(lower fatty acid)-substituted glutathione derivative
10/02/1996EP0275285B1 Biodegradable superparamagnetic materials used in clinical applications
10/02/1996DE19512181A1 Transdermal applizierbares Arzneimittel mit ACE-Hemmern Transdermally administrable drug with ACE inhibitors
10/02/1996DE19512142A1 Infektiöser cDNA-Klon des Tick-Borne Enzephalitis (TBE)-Virus, davon abgeleiteter rekombinanter Impfstoff und Herstellung desselben sowie ein pharmazeutisches Produkt, das eine replizierbare Nukleinsäure enthält Infectious cDNA clone of the tick-borne encephalitis (TBE) virus derived therefrom recombinant vaccine and the preparation thereof and a pharmaceutical product containing a replicable nucleic acid
10/02/1996CN1132527A G-CSF analogue compsn. and its prepn. method
10/02/1996CN1132516A Monoclonal IgA antibody against respiratory syncytial virus
10/02/1996CN1132515A Novel peptide, active as inhibitors of platelet aggregation
10/02/1996CN1132514A Protective antigens against parasites
10/02/1996CN1132504A Inhibitor of inhibiting generation of beta-amyloid
10/02/1996CN1132252A Antibiotic wap-8294A, method for preparing the same and antibactercal composition
10/02/1996CN1132249A Process for inactivation of viruses with aid of acridine or acridine derivatives
10/02/1996CN1132212A Method for crystallizing interferon alpha-2
10/02/1996CN1132210A Cyclohexapeptides and their mixtures, process for preparing them, and their use
10/02/1996CN1132098A Human leucocyte interferon spray
10/02/1996CN1132076A Fully-powdered capsule of shark and its prepn. technique
10/01/1996US5561146 Modified guanidino and amidino thrombin inhibitors
10/01/1996US5561119 Glycosylated prodrugs, their method of preparation and their uses
10/01/1996US5561115 Therapeutic solutions
10/01/1996US5561113 Analgesics; antiiflammatory agents; gastrointestinal, urogenital and nervous system(cns) disorders; asthma; antiallergens
10/01/1996US5561112 Pseudopeptide isosteres of gly-asp and their use as antithrombic agents
10/01/1996US5561111 Stable glutamine derivatives for oral and intravenous rehydration and nutrition therapy
10/01/1996US5561110 Administering oligopeptide
10/01/1996US5561109 Method for the healing of wounds caused by corneal injury
10/01/1996US5561108 Preparation of α1 -antichymotrypsin
10/01/1996US5561107 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
10/01/1996US5561050 Methods for diagnosis of colon, stomach and pancreatic cancer using antibodies specific for a mucin-type carbohydrate chain
10/01/1996US5561046 Methods for the detection of acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
10/01/1996US5561043 Genetic engineering
10/01/1996US5560936 Intrinsic inhibitors of aldose reductase
10/01/1996US5560915 Composition for treating IgE mediated allergies comprising substance P and allergen
10/01/1996US5560911 Method of inhibiting acute complement mediated cytotoxicity with anti-idiotypic antibodies
10/01/1996US5560910 Topical anti-inflammatory composition and method
10/01/1996US5560908 Noninsulin dependent diabetes mellitus; administering cytokine
10/01/1996CA2172659A1 Fungal cell wall protein cly4
10/01/1996CA1338627C Pharmaceuticals based on phosphoric acid esters for use in tumor therapy, and process for their preparation
10/01/1996CA1338619C Lectin complex and method and probe for making same
10/01/1996CA1338618C Vaccine adjuvant
09/1996
09/28/1996CA2172685A1 Adjuvant based on colloidal iron compounds
09/26/1996WO1996029605A2 Compounds and methods for the dectection of t. cruzi infection
09/26/1996WO1996029433A1 Rest protein and dna
09/26/1996WO1996029425A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
09/26/1996WO1996029417A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996WO1996029416A1 Aspergillus arabinofuranosidase
09/26/1996WO1996029412A1 Proteinase k resistant surface protein of neisseria meningitidis
09/26/1996WO1996029411A1 Protein production and delivery
09/26/1996WO1996029409A2 Rage tumor rejection antigens
09/26/1996WO1996029408A1 Il-17 receptor
09/26/1996WO1996029407A2 Cellubrevin homologs
09/26/1996WO1996029406A2 Nuclear localization factor associated with circadian rhythms
09/26/1996WO1996029405A2 MODULATORS OF ob GENE AND SCREENING METHODS THEREFOR
09/26/1996WO1996029403A1 Bcl2 derived genetic elements associated with sensitivity to chemotherapeutic drugs
09/26/1996WO1996029401A1 Human b-cell translocation genes-2 and 3
09/26/1996WO1996029399A1 Antisense oligonucleotides for inhibiting helicobacter pylori activity
09/26/1996WO1996029350A1 MONOCLONAL ANTIBODY REACTING SPECIFICALLY WITH Fas LIGAND AND PROCESS FOR PRODUCING THE SAME
09/26/1996WO1996029348A1 Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseases
09/26/1996WO1996029347A1 Thrombin inhibitors based on the amino acid sequence of hirudin
09/26/1996WO1996029346A1 Stable polymerized hemoglobin blood-substitute
09/26/1996WO1996029344A1 Insulin derivatives
09/26/1996WO1996029342A1 Lipophilic peptide hormone derivatives
09/26/1996WO1996029341A1 Human stat4
09/26/1996WO1996029340A1 Casein phosphopeptide, casein containing same and process for the preparation thereof
09/26/1996WO1996029339A1 Fucopeptides
09/26/1996WO1996029313A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
09/26/1996WO1996029304A1 Nonpeptides as tachykinin antagonists
09/26/1996WO1996029095A1 Hcg liquid formulations
09/26/1996WO1996029094A1 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
09/26/1996WO1996029092A1 Corneal vascularization inhibitor
09/26/1996WO1996029091A1 Treatment of papillomavirus-associated lesions using interleukin-12
09/26/1996WO1996029090A1 Agent for influencing cell differentiation and use thereof
09/26/1996WO1996029089A1 A novel ras p21-interacting protein and uses thereof
09/26/1996WO1996029088A1 Novel piperazine derivatives as type il-1 receptor antagonists
09/26/1996WO1996029087A1 Methods for reduced renal uptake of antibody fragments
09/26/1996WO1996029086A1 Compositions and methods for reducing adhesiveness of defective red blood cells
09/26/1996WO1996029065A2 Aminotetralin derivative for the therapy of cardiovascular diseases
09/26/1996WO1996024373A3 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
09/26/1996WO1996024372A3 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
09/26/1996WO1996023071A3 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY
09/26/1996WO1996023065A3 Inhibition of neovascularization using vegf-specific oligonucleotides
09/26/1996WO1996022760A3 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
09/26/1996WO1996021014A3 Production and administration of high titer recombinant retroviruses
09/26/1996WO1996017924A3 Novel hedgehog-derived polypeptides
09/26/1996WO1996011272A3 Papilloma virus-like particles, fusion proteins and process for producing the same
09/26/1996CA2216147A1 Cellubrevin homologs
09/26/1996CA2215936A1 Hcg liquid formulations
09/26/1996CA2215905A1 Monoclonal antibody reacting specifically with fas ligand and process for producing the same
09/26/1996CA2215739A1 Lipophilic peptide hormone derivatives
09/26/1996CA2215702A1 Thrombin inhibitors based on the amino acid sequence of hirudin
09/26/1996CA2215694A1 Insulin derivatives
09/26/1996CA2215671A1 Aminotetralin derivative for the therapy of cardiovascular diseases
09/26/1996CA2215618A1 Protein production and delivery
09/26/1996CA2215525A1 Treatment of papillomavirus-associated lesions using interleukin-12
09/26/1996CA2215449A1 Antisense oligonucleotides for inhibiting helicobacter pylori activity
09/26/1996CA2215414A1 Compositions and methods for reducing adhesiveness of defective red blood cells
09/26/1996CA2215387A1 Modulators of ob gene and screening methods therefor
1 ... 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 ... 3163